Wegovy is FDA-approved for chronic weight management in adults and pediatric patients aged 12 years and older with obesity (BMI 30 kg/m for adults, 95th percentile for age and sex in pediatrics) or overweight (BMI 27 kg/m for adults, 85th percentile for pediatrics) with at least one weight-related comorbidity
Too much semaglutide can cause nausea, vomiting, diarrhea, abdominal pain, or dehydration
Finally, refer to the specific administration instructions provided with your medication to ensure accuracy
Use a U-100 insulin syringe, which is the standard type where 100 units equals 1mL
Expected effects at 0.25 mg (10 units from 2.5 mg/mL) This is the lowest standard dose
When to contact your healthcare provider about dosing Dose conversion math is something you can and should be able to do yourself